ATHA
Price
$4.18
Change
+$0.24 (+6.09%)
Updated
Mar 4, 12:20 PM EST
66 days until earnings call
NUVB
Price
$2.23
Change
+$0.36 (+19.25%)
Updated
Mar 1, 6:59 PM EST
70 days until earnings call
Ad is loading...

Analysis and predictions ATHA vs NUVB

Header iconATHA vs NUVB Comparison
Open Charts ATHA vs NUVBBanner chart's image
Athira Pharma
Price$4.18
Change+$0.24 (+6.09%)
Volume$1.42K
CapitalizationN/A
Nuvation Bio
Price$2.23
Change+$0.36 (+19.25%)
Volume$1.17M
CapitalizationN/A
View a ticker or compare two or three
ATHA vs NUVB Comparison Chart

Loading...

ATHADaily Signal changed days agoGain/Loss if shorted
 
Show more...
NUVBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
ATHA vs. NUVB commentary
Mar 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATHA is a Hold and NUVB is a StrongBuy.

COMPARISON
Comparison
Mar 04, 2024
Stock price -- (ATHA: $3.94 vs. NUVB: $2.23)
Brand notoriety: ATHA and NUVB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATHA: 52% vs. NUVB: 365%
Market capitalization -- ATHA: $151.01M vs. NUVB: $488.47M
ATHA [@Biotechnology] is valued at $151.01M. NUVB’s [@Biotechnology] market capitalization is $488.47M. The market cap for tickers in the [@Biotechnology] industry ranges from $550.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.62B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATHA’s FA Score shows that 1 FA rating(s) are green whileNUVB’s FA Score has 1 green FA rating(s).

  • ATHA’s FA Score: 1 green, 4 red.
  • NUVB’s FA Score: 1 green, 4 red.
According to our system of comparison, both ATHA and NUVB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATHA’s TA Score shows that 5 TA indicator(s) are bullish while NUVB’s TA Score has 4 bullish TA indicator(s).

  • ATHA’s TA Score: 5 bullish, 4 bearish.
  • NUVB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ATHA is a better buy in the short-term than NUVB.

Price Growth

ATHA (@Biotechnology) experienced а +0.25% price change this week, while NUVB (@Biotechnology) price change was +25.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.33%. For the same industry, the average monthly price growth was +19.10%, and the average quarterly price growth was +52.85%.

Reported Earning Dates

ATHA is expected to report earnings on May 09, 2024.

NUVB is expected to report earnings on May 13, 2024.

Industries' Descriptions

@Biotechnology (+4.33% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for ATHA with price predictions.
OPEN
A.I.dvisor published
a Summary for NUVB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NUVB($488M) has a higher market cap than ATHA($151M). ATHA YTD gains are higher at: 62.140 vs. NUVB (47.682). NUVB has higher annual earnings (EBITDA): -103.11M vs. ATHA (-125.97M). NUVB has more cash in the bank: 619M vs. ATHA (147M). ATHA has less debt than NUVB: ATHA (1.59M) vs NUVB (4.46M). ATHA (0) and NUVB (0) have equivalent revenues.
ATHANUVBATHA / NUVB
Capitalization151M488M31%
EBITDA-125.97M-103.11M122%
Gain YTD62.14047.682130%
P/E RatioN/AN/A-
Revenue00-
Total Cash147M619M24%
Total Debt1.59M4.46M36%
TECHNICAL ANALYSIS
Technical Analysis
ATHANUVB
RSI
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
89%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
79%
MACD
ODDS (%)
Bullish Trend 4 days ago
70%
Bullish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
78%
Advances
ODDS (%)
Bullish Trend 19 days ago
83%
Bullish Trend 7 days ago
73%
Declines
ODDS (%)
Bearish Trend 5 days ago
87%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
68%
Bullish Trend 4 days ago
78%
View a ticker or compare two or three
Ad is loading...
ATHADaily Signal changed days agoGain/Loss if shorted
 
Show more...
NUVBDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSSGX12.450.20
+1.63%
Morgan Stanley Inst Inception I
JSEAX19.220.23
+1.21%
JPMorgan International Equity A
RBCIX7.960.09
+1.14%
RBC China Equity I
GCMCX28.750.20
+0.70%
Goldman Sachs Mid Cap Value C
IRSAX15.990.10
+0.63%
Delaware Real Estate Securities A

ATHA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATHA has been loosely correlated with OCUL. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ATHA jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATHA
1D Price
Change %
ATHA100%
+2.34%
OCUL - ATHA
41%
Loosely correlated
+6.86%
NUVB - ATHA
39%
Loosely correlated
+19.25%
CRSP - ATHA
38%
Loosely correlated
-0.56%
ALNY - ATHA
35%
Loosely correlated
+1.01%
ATNM - ATHA
34%
Loosely correlated
-0.70%
More

NUVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVB has been loosely correlated with NTLA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVB jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVB
1D Price
Change %
NUVB100%
+19.25%
NTLA - NUVB
47%
Loosely correlated
+1.68%
VCYT - NUVB
43%
Loosely correlated
+1.91%
SRNEQ - NUVB
43%
Loosely correlated
-25.93%
RGNX - NUVB
42%
Loosely correlated
+21.50%
CRDF - NUVB
40%
Loosely correlated
+64.87%
More